Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Psychopharmacological Prescribing Patterns Among Italian Adolescents With Anorexia Nervosa: Exploring Real-World Treatment Practices.

Created on 02 Nov 2026

Authors

Marika Orlandi, Arianna Vecchio, Giulia Andorno, Maria Pia Riccio, Cinzia Crispino, Martina Maria Mensi

Published in

European eating disorders review : the journal of the Eating Disorders Association. Volume 34. Issue 6. Pages 1626-1636. Epub Jul 08, 2026.

Abstract

To investigate real-world psychopharmacological prescribing patterns among Italian adolescents with anorexia nervosa (AN) compared with psychiatric controls without eating disorders, and to examine whether AN diagnosis independently predicts medication use after accounting for psychiatric comorbidities. Participants were recruited from two Italian Child and Adolescent Neuropsychiatry services to improve the representativeness of prescribing practices across different clinical settings within the Italian healthcare system.
This cross-sectional cohort study included 298 female adolescents (aged 12-18 years) from 2017 to 2025. Participants were classified into AN (n = 149) and control (n = 149) groups based on DSM-5/DSM-5-TR diagnoses. Sociodemographic, clinical, and pharmacological data were collected. Multivariable logistic regression models examined associations between diagnosis and prescription of any psychotropic medication, specific drug classes, and polypharmacy (≥ 2 psychotropic classes), adjusting for psychiatric comorbidities while accounting for potential site-related differences in local prescribing practices.
Psychotropic medication use was more frequent among controls in unadjusted analyses. In multivariable models, AN diagnosis was not independently associated with the prescription of any psychotropic medication, antipsychotics, or antidepressants. In contrast, AN group showed a significantly higher likelihood of receiving benzodiazepines (aOR = 2.76, 95% CI 1.43-5.47) and polypharmacy (aOR = 2.37, 95%CI 1.23-4.64) compared with controls. Polypharmacy was also independently associated with psychotic disorders, personality disorders, and depressive disorders.
In this multicenter Italian real-world cohort, psychopharmacological treatment in adolescents with AN appeared to be primarily driven by psychiatric comorbidities rather than AN diagnosis itself. However, benzodiazepine use and higher rates of polypharmacy in AN may reflect disorder-specific clinical features and unmet treatment needs. These findings highlight the complexity of pharmacological management in adolescent AN and the need for more robust, disorder-specific evidence to guide clinical practice.

PMID:
42415684
Bibliographic data and abstract were imported from PubMed on 02 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement